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Objectively measured sleep duration and plasma glucose values 
following an oral glucose tolerance test amongst pregnant women 
with obesity in the UK.    
Abstract 
Background/objectives: Short sleep duration has been linked to maternal hyperglycaemia following a 
1-hour 50g oral glucose tolerance test (OGTT) in observational studies conducted primarily in the 
USA. Our objective was to examine the relationship between objectively measured sleep duration 
and plasma glucose values following the 2-hour 75g OGTT routinely used in the UK amongst women 
with obesity.   
Methods: Sleep and OGTT data were available for 49 pregnant women who wore wrist actigraphs 
for at least 2 nights, and took a 2-hour 75g OGTT at the end of their second trimester. Multivariable 
regression was used to evaluate associations between sleep duration and OGTT results.  
Results: Higher 2-hour plasma glucose values were significantly associated with shorter sleep 
duration and higher maternal age and BMI, with no association observed between wake after sleep 
onset (WASO) and 2-hour plasma glucose values. No associations were observed between fasting 
plasma glucose values and any sleep parameters.  
Conclusions: We found that shorter sleep duration, as measured using actigraphy, is associated with 
higher 2-hour plasma glucose values following a 2-hour 75g OGTT in the UK. These findings are in 
keeping with those observed elsewhere in the world, employing alternative OGTT protocols. Future 
studies should investigate sleep extension as a potential candidate for inclusion in future RCTs 
aiming to improve glucose tolerance and prevent GDM amongst those at risk. 
Keywords: Pregnancy, sleep duration, glucose tolerance, obesity, actigraphy.   
1. Introduction 
It is well documented that maternal obesity, excessive gestational weight gain and the development 
of gestational diabetes mellitus are risk factors for multiple adverse maternal and infant outcomes 
during pregnancy [1–3]. Numerous maternal lifestyle interventions aiming to limit gestational weight 
gain, prevent gestational diabetes mellitus and improve other maternal and infant outcomes have 
been conducted to date, with the majority of studies focusing on diet and physical activity [4,5].  
Sleep is another potentially modifiable maternal lifestyle factor, and short sleep duration has been 
associated with metabolic disturbances and increased risk of obesity and type 2 diabetes in non-
pregnant populations [6]. A recent meta-analysis of individual patient data demonstrated that 
objectively measured short sleep duration during pregnancy (<6.5 hours) was associated with higher 
1-hour glucose levels following a 50g oral glucose tolerance test (OGTT) and increased risk of 
gestational diabetes melitus [7]. However, of the four studies included in analysis, three measured 
sleep duration using a single overnight polysomnography (PSG), which as the authors acknowledge, 
may not reflect habitual sleep duration as measured by actigraphy, which was reported for just one 
study.  
The diagnostic criteria for gestational diabetes mellitus varies worldwide, as does the dose of 
glucose administered as part of an OGTT. In the UK, the National Institute for Health and Care 
Excellence (NICE) recommend the use of the 2-hour 75g OGTT to test for gestational diabetes 
mellitus in women with known risk factors [8]. The studies included in Reutrakul and colleagues’ 
meta-analysis [7] were conducted in the US or Canada with different diagnostic criteria for 
gestational diabetes mellitus. To our knowledge, no studies have examined the impact of objectively 
measured sleep duration on blood glucose values following a 75g 2-hour OGTT according to NICE 
guidelines in the UK. It is important to ascertain whether a relationship exists before sleep is 
considered for incorporation into RCTs or antenatal advice in the UK. The aim of the present study is 
to investigate the impact of sleep duration assessed using actigraphy on OGTT results amongst a 
cohort of women with obesity in Plymouth, UK.  
2. Materials and methods  
2.1. Study population and design 
Participants in the present study were part of a larger observational study examining the impact of 
GWG, diet and physical activity on maternal and infant outcomes, the results of which are described 
elsewhere (in press).  
Inclusion criteria included: age ≥18 and <40 years, BMI ≥ 30 and <40 kg/m2, gestation ≤12 weeks at 
first antenatal appointment and a singleton pregnancy. Women with multiple pregnancies, pre-
existing type I or type II diabetes mellitus or women identifying as any ethnicity other than white 
Caucasian were not eligible to participate, as the study was not powered to detect differences 
between these groups. Eligible women were identified from their first antenatal appointment notes 
and approached at their 12 week dating scan at Derriford Hospital in Plymouth, UK. Ethical approval 
was obtained from the NHS Health Research Authority National Research Ethics Service and local 
approval was obtained from Plymouth Hospitals NHS Trust. 
2.2. Data collection 
Following recruitment, verbal and written informed consent was obtained, and a questionnaire was 
administered to participants between 12 and 14 weeks gestation.  
In the present study, sleep data were collected at the end of the second trimester. Women wore an 
Actigraph wrist-worn accelerometer (Actigraph wGT3X-BT, Florida, USA) on their dominant wrist for 
four days following the study visit, after which the device was analysed on the corresponding 
computer software program (Actilife 6.0, Florida, USA).  
Participants with <2 valid days of sleep data were excluded from analyses. Sleep was identified using 
the Cole-Kripke sleep scoring algorithm [9] which has been validated for use in an adult population 
and recently used to assess sleep duration and disruption in late pregnancy [10]. For each 
participant, mean sleep duration, mean wake after sleep onset (WASO), WASO as a percentage of 
total sleep and sleep fragmentation was reported. WASO is defined as the total minutes spent 
awake between the onset of sleep and the end of rest interval, while sleep fragmentation is an index 
of restlessness during the sleep period expressed as a percentage.  
All women enrolled in the study received a routine 2-hour 75g OGTT at approximately 28 weeks, as 
per NICE guidance [8]. Fasting and 2-hour plasma glucose values were reported in mmol and the 
incidence of gestational diabetes mellitus according to NICE diagnostic criteria was recorded for each 
participant.  
2.3. Statistical analysis 
All data were entered into and analysed using SPSS (Statistics Package for the Social Sciences) for 
Windows version 21 (IBM, Chicago USA). The level of significance was set to a probability (p) < 0.05 
for all statistical tests performed. Multiple regression was used to evaluate the extent to which 
maternal sleep duration and WASO influence maternal fasting and 2-hour plasma glucose values 
following an OGTT after adjustment for age and BMI at first antenatal appointment. Sleep 
fragmentation was not included in the model in order to avoid multi-collinearity, as it was correlated 
with WASO.   
3. Results 
Of 75 women enrolled in the study, 49 had at least 2 days of valid sleep data in trimester two and an 
OGTT result. Table 1 shows the descriptive characteristics of these women. Women slept for an 
average of 7.0 ± 0.3 hours per night and the average time spent in WASO was 9.0 ± 4.3 %. Ten of the 







Table 1 Maternal characteristics  
 n=49 
Age, years 30.0 ± 4.4 
BMI, kg/m2 33.2 ± 2.1 
Nulliparous, n (%) 20 (40.8) 
Median gestation at sleep 
data collection, weeks + days 
(IQR) 
28 + 4 (5.5) 
Fasting glucose, mmol/l 4.6 ± 0.6 
2-hour glucose, mmol/l 6.3 ± 1.6 
GDM diagnosis, n (%) 10 (20.4) 
Sleep duration, hours 7.0 ± 0.3 
WASO, minutes 35.2 ± 17.1 
WASO, % 9.0 ± 4.3 
Sleep fragmentation index, % 27.4 ± 14.9 
Mean ± SD unless otherwise stated  
IQR: interquartile range. 
GDM: gestational diabetes mellitus 
 
No statistically significant associations were found between maternal age, BMI, sleep duration or 
WASO and fasting plasma glucose values. Higher 2-hour plasma glucose values were significantly 
associated with shorter sleep duration, higher maternal age and higher maternal BMI, with no 
association observed between WASO and 2-hour plasma glucose values (Table 2).  
Table 2 Summary of multiple regression analyses for associations between blood glucose, maternal age, BMI, sleep 
duration and WASO. 
 Fasting glucose 2-hour glucose 
 β 95% CI p β 95% CI p 
Maternal age, 
years 
0.11 -0.027 – 0.058 0.477 0.41 0.045 – 0.246 0.006 
BMI, kg/m2 0.21 -0.026 – 0.145 0.165 0.28 -0.011 – 0.414 0.036 
Sleep duration, 
minutes 
-0.05 -0.002 – 0.002 0.777 -0.35 -0.009 – -0.001 0.025 
WASO, % 0.05 -0.043 – 0.057 0.774 -0.04 -0.131 – 0.103 0.809 
 
4. Discussion 
Results from our study indicate that sleep duration is inversely associated with 2-hour, but not 
fasting plasma glucose values, following a 2-hour 75g OGTT, even after adjustment for maternal age, 
BMI and WASO. To our knowledge, this is the first study to examine the impact of objectively 
measured sleep duration using actigraphy on plasma glucose values amongst women in the UK, who 
receive a 2-hour 75g OGTT according to NICE guidelines [8].  
Findings from our study are similar to those of Herring et al. [11] who observed that objectively 
measured short sleep duration using actigraphy was associated with incidence of gestational 
diabetes mellitus and higher 1-hour plasma glucose values following a 50g-OGTT in their cohort of 
63 low-income urban women in the US. Other studies using self-reported measures of sleep 
duration have also reported an inverse relationship [12], and in some cases a U-shaped relationship 
between sleep duration and incidence of gestational diabetes mellitus [13]. Findings from the 
present study therefore suggest that the relationship between sleep duration and glucose 
intolerance is similar for women in the UK undergoing a 75g 2-hour OGTT to those in the US, who 
have typically undergone a 50g 2-hour OGTT in the current literature [7].  
Experimental data from non-pregnant populations has demonstrated adverse effects on glucose 
tolerance, insulin response, insulin sensitivity and glucose disposal with short sleep, but not regular 
sleep  [14,15]. To our knowledge, no such experimental data has been collected from women during 
pregnancy, but Twedt and colleagues are currently conducting a pilot RCT to determine whether 
sleep education during pregnancy improves glycemic control amongst women with gestational 
diabetes mellitus in Pittsburgh, US [16].  
A strength of the present study is that sleep duration has been measured objectively using 
actigraphy. Actigraphy correlates well with PSG and enables the assessment of habitual sleep in 
research participants’ homes rather than in the laboratory [17]. Actigraphy has also been shown to 
be preferable to self-report questionnaires for estimation of sleep duration during pregnancy [18]. 
The accelerometers were programmed to collect data from 00.00 to 00.00 over four days, as a 
primary aim of the study was to collect 4 days of physical activity data. This meant that two nights of 
potential sleep data collection were interrupted, so that only a maximum of three night’s data were 
available for each participant.  
The present study was conducted amongst a cohort of women with obesity, with a BMI ≥ 30 and < 
40 kg/m2. Obesity is a well-documented risk factor for impaired glucose metabolism during 
pregnancy and GDM [2], and the majority of intervention studies aiming to prevent gestational 
diabetes mellitusvhave been conducted amongst this group of women [19]. The women in this 
cohort were all receiving antenatal care in Plymouth, UK, where the majority of women are White 
Caucasian. As such, only women from this group were eligible to participate, as the study was not 
powered to identify differences between other ethnic groups without recruiting a larger sample of 
women, which was not feasible. As the prevalence of gestational diabetes mellitus is well-known to 
vary between different ethnic groups [20], the findings from the present study cannot be 
generalised beyond the present population. Future work in a larger cohort should include women of 
different ethnicities and from different geographical areas of the UK.  It was also not possible to 
include daytime sleeping in our analysis as the majority of women did not sleep during the day, and 
thus the study was not powered to examine whether this practice influenced plasma glucose values. 
This is something that should be examined in future work, in a larger cohort.  
In summary, we found that shorter sleep duration, as measured using actigraphy, is associated with 
higher 2-hour plasma glucose values following a 2-hour 75g OGTT in the UK, after adjustment for 
age, maternal BMI and WASO. These findings are in keeping with those observed elsewhere in the 
world, with different OGTT protocols, and thus suggest sleep extension as a potential candidate for 
inclusion in future RCTs aiming to improve glucose tolerance and prevent gestational diabetes 
mellitus amongst those at risk. However, since long sleep duration has also been associated with 
impaired glucose tolerance and risk of gestational diabetes mellitus, larger, more diverse studies 
using objective measures of sleep duration are first required in order to identify optimal sleep 
duration during pregnancy.  
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